Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Epilepsia|March 7, 2014
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactionsUrsula Amstutz, Neil H Shear, Michael J Rieder, et al.
The Journal of Pediatrics|September 2, 2011
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesiaJessica Lam, Lauren Kelly, Catherine Ciszkowski, et al.
Pain Research & Management|June 11, 2013
Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful?Parvaz Madadi, Johanna Sistonen, Gregory Silverman, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 30, 2009
Aluminum content of parenteral nutrition in neonates: measured versus calculated levelsRobert L Poole, Linda Schiff, Susan R Hintz, et al.
Plos One|November 4, 2022
All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicityJafar S Hasbullah, Erika N Scott, Amit P Bhavsar, et al.
Vaccine|February 21, 2023
Vaccinomics: A scoping reviewMatthew Z Dudley, Jennifer E Gerber, Haley Budigan Ni, et al.
Therapeutic Drug Monitoring|July 18, 2015
Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin TherapyKaitlyn Shaw, Ursula Amstutz, Richard B Kim, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 6, 2012
Aluminum in pediatric parenteral nutrition products: measured versus labeled contentRobert L Poole, Kevin P Pieroni, Shabnam Gaskari, et al.
Anesthesia and Analgesia|December 11, 2024
The Influence of Pharmacogenetic Factors on the Pharmacokinetics of Morphine and Its Metabolites in Pediatric Patients: A Systematic ReviewKheireddin Mufti, José Eduardo Juárez-Hernández, Niloofar Gheshlaghi, et al.
Breast Cancer Research and Treatment|November 10, 2018
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelinesBritt I Drögemöller, Galen E B Wright, Joanne Shih, et al.
Pageof 14